Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 1 Study to Assess the Effect of Rifampin on the Pharmacokinetics of ABT-199

NCT01969682 is registered in ClinicalTrials.gov with AbbVie as lead sponsor.

NCT NCT01969682
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01969682 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 1 Study to Assess the Effect of Rifampin on the Pharmacokinetics of ABT-199
Lead sponsor
AbbVie
Phase
Phase 1
Overall status
Withdrawn
Start date
April 30, 2014
Completion date
May 31, 2014
Enrollment
0 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

non-hodgkin's lymphoma